For its ability to improve well-being (QoL), osimertinib, a revolutionary precision treatment for individuals with lung cancer, has been hailed.The healthcare professionals continues to investigate advantages of this medication. Consequently, comprehending its effect on patients' QoL becomes crucial.This article delves into the multiple facets of osimertinib's role in improving well-being. It highlights the key areas where this medication makes a significant difference.A potent tyrosine kinase inhibitor (TKI) that targets particular genetic alterations in the EGFR gene, commonly found in adenocarcinoma of the lung (NSCLC), is osimertinib.suppressing proliferation of cancer cells…
